Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
Clinical trial NCT06955169 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06955169
- Sponsor
- RTOG Foundation, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-24
- Primary completion
- 2029-08-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.